Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CinCor Pharma, Inc. - Common Stock (NQ: CINC ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 23, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about CinCor Pharma, Inc. - Common Stock < Previous 1 2 3 4 Next > CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat February 21, 2023 From CinCor Pharma Inc Via GlobeNewswire There's a Lot to Love About Mineralys' Valentine's Day IPO February 13, 2023 MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million Via MarketBeat Topics Initial Public Offering Exposures Securities Market These 2 Healthcare Stocks Have Doubled in 2023 February 01, 2023 Wouldn’t it be great if a stock had a bulkier capitalization and 2x potential? This is rare but possible for these two small-mid health care stocks. Via MarketBeat CINCOR PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC January 24, 2023 From Kahn Swick & Foti, LLC Via Business Wire Where CinCor Pharma Stands With Analysts January 12, 2023 Via Benzinga Where CinCor Pharma Stands With Analysts December 07, 2022 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT) January 20, 2023 From Brodsky & Smith LLC Via GlobeNewswire Why These Two Biotech Stocks Blasted Higher This Week January 13, 2023 There's nothing like a big-premium buyout to send a company's share price to the moon. Via The Motley Fool Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review January 13, 2023 Sharp Tesla price cuts and some notable earnings were in focus. Via Investor's Business Daily CINCOR PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC January 10, 2023 From Kahn Swick & Foti, LLC Via Business Wire AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout January 10, 2023 CinCor will bolster AstraZeneca's growing cardio-renal business. Via Investor's Business Daily BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT) January 10, 2023 From Brodsky & Smith LLC Via GlobeNewswire S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher January 09, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday. Via Benzinga Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 09, 2023 Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 09, 2023 Via Benzinga Stocks Building Off Of Friday's Rally January 09, 2023 The Dow Jones Industrial Average is up more than 280 points midday, while the Nasdaq Composite Index is also up triple digits. Via Talk Markets Nasdaq Surges Over 200 Points; Crude Oil Rises 2% January 09, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday. Via Benzinga CinCor Pharma (NASDAQ: CINC) Enters Into Agreement to be Acquired by AstraZeneca (NASDAQ: AZN) for $1.3 Billion January 09, 2023 CinCor Pharma, Inc. (NASDAQ: CINC) is a clinical-stage biopharmaceutical company, which is focused on the research and development of treatments Via Spotlight Growth AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal January 09, 2023 AstraZeneca stock wavered as it agreed to buy CinCor Pharma, maker of blood pressure drug baxdrostat for $1.8 billion. CINC stock soared. Via Investor's Business Daily Why Is CinCor (CINC) Stock Up 138% Today? January 09, 2023 CinCor (CINC) stock is rocketing higher on Monday following news that AstraZeneca (AZN) is acquiring the company for up to $1.8 billion. Via InvestorPlace Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday January 09, 2023 U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga US Stocks Open Higher; Dow Rises 150 Points January 09, 2023 U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday. Via Benzinga CINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CinCor Pharma, Inc. Is Fair to Shareholders January 09, 2023 From Halper Sadeh LLC Via Business Wire Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories January 09, 2023 Bloomberg Via Benzinga AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline January 09, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session January 09, 2023 Via Benzinga Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket January 09, 2023 Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday January 09, 2023 We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning! Via InvestorPlace CinCor Pharma to be Acquired by AstraZeneca January 09, 2023 From CinCor Pharma Inc Via GlobeNewswire Analyzing CinCor Pharma's Short Interest January 03, 2023 CinCor Pharma's (NASDAQ:CINC) short percent of float has risen 4.28% since its last report. The company recently reported that it has 2.25 million shares sold short, which is 8.78% of all regular... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.